| 2024-01-23 |
复牌提示：
2024-01-22 19:50:00 停牌，复牌日期 2024-01-24 00:00:01
|
| 2024-01-16 |
详情>>
内部人交易：
Hickey Benjamin等共交易4笔
|
| 2023-11-06 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-8.66美元,归母净利润-5.23亿美元,同比去年增长2.78%
|
| 2023-11-02 |
股东大会：
将于2023-12-13召开股东大会
会议内容 ▼▲
- 1.To consider and vote on the proposal to adopt the Agreement and Plan of Merger (which we refer to, as it may be amended from time to time, as the “Merger Agreement”), dated October 8, 2023, by and among Mirati, Bristol-Myers Squibb Company, a Delaware corporation (which we refer to as “BMS” or “Parent”), and Vineyard Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Parent (which we refer to as “Merger Sub”), including the form of contingent value rights agreement to be entered into at or immediately prior to the effective time of the Merger by Parent and a rights agent reasonably acceptable to Mirati (which we refer to as the “CVR Agreement”). Pursuant to the terms of the Merger Agreement, Merger Sub will merge with and into Mirati (which we refer to as the “Merger”), with Mirati surviving the Merger as a wholly owned subsidiary of Parent (we refer to this proposal as the “Merger Proposal”);
2.To consider and vote on the proposal to approve, by non-binding, advisory vote, compensation that may be paid or become payable by Mirati to its named executive officers in connection with the Merger (we refer to this proposal as the “Compensation Proposal”);
3.To consider and vote on any proposal to adjourn the Special Meeting to a later date or dates if necessary or appropriate to solicit additional proxies if there are insufficient votes to approve the Merger Proposal at the time of the Special Meeting (we refer to this proposal as the “Adjournment Proposal”).
|
| 2023-11-02 |
详情>>
股本变动：
变动后总股本7014.77万股
|
| 2023-08-08 |
详情>>
业绩披露：
2023年中报每股收益-6.22美元,归母净利润-3.61亿美元,同比去年增长0.91%
|
| 2023-08-08 |
财报披露：
美东时间 2023-08-08 盘后发布财报
|
| 2023-05-09 |
详情>>
业绩披露：
2023年一季报每股收益-3.18美元,归母净利润-1.85亿美元,同比去年增长2.02%
|
| 2023-04-06 |
股东大会：
将于2023-05-11召开股东大会
会议内容 ▼▲
- 1.To elect the nine nominees for director named in the accompanying proxy statement to serve for the ensuing year and until their successors are elected.
2.To approve, on an advisory basis, compensation paid to our named executive officers as disclosed in this proxy statement.
3.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2023.
4.To approve the amendment to our 2013 Employee Stock Purchase Plan, to increase the aggregate number of shares of our common stock reserved for issuance under such plan by 750,000 shares.
5.To conduct any other business properly brought before the meeting.
|
| 2023-02-28 |
详情>>
业绩披露：
2020年年报每股收益-7.96美元,归母净利润-3.58亿美元,同比去年增长-67.84%
|
| 2023-02-28 |
详情>>
业绩披露：
2022年年报每股收益-13.18美元,归母净利润-7.41亿美元,同比去年增长-27.34%
|
| 2022-11-08 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-9.66美元,归母净利润-5.38亿美元,同比去年增长-40.88%
|
| 2022-08-03 |
详情>>
业绩披露：
2021年中报每股收益-5.91美元,归母净利润-3.02亿美元,同比去年增长-78.22%
|
| 2022-08-03 |
详情>>
业绩披露：
2022年中报每股收益-6.57美元,归母净利润-3.65亿美元,同比去年增长-20.76%
|
| 2022-05-04 |
详情>>
业绩披露：
2022年一季报每股收益-3.4美元,归母净利润-1.88亿美元,同比去年增长-38.85%
|
| 2022-04-15 |
股东大会：
将于2022-05-12召开股东大会
会议内容 ▼▲
- 1.To elect the ten nominees for director named in the accompanying proxy statement to serve for the ensuing year and until their successors are elected.
2.To approve, on an advisory basis, compensation paid to our named executive officers as disclosed in this proxy statement.
3.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2022.
4.To approve our 2022 Equity Incentive Plan.
5.To conduct any other business properly brought before the meeting.
|
| 2022-02-28 |
详情>>
业绩披露：
2021年年报每股收益-11.21美元,归母净利润-5.82亿美元,同比去年增长-62.54%
|
| 2021-11-08 |
详情>>
业绩披露：
2021年三季报(累计)每股收益-7.45美元,归母净利润-3.82亿美元,同比去年增长-48.79%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-16 |
股东大会：
将于2021-05-12召开股东大会
会议内容 ▼▲
- 1.To elect the ten nominees for director named in the accompanying proxy statement to serve for the ensuing year and until their successors are elected.
2.To approve, on an advisory basis, compensation paid to our named executive officers as disclosed in this proxy statement.
3.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2021.
4.To approve our Amended and Restated 2013 Equity Incentive Plan, to among other things, increase the aggregate number of shares of our common stock authorized for issuance under such plan by 2,500,000 shares.
5.To conduct any other business properly brought before the meeting.
|
| 2020-04-17 |
股东大会：
将于2020-05-12召开股东大会
会议内容 ▼▲
- 1.To elect the nine nominees for director named in the accompanying proxy statement to serve for the ensuing year and until their successors are elected.
2.To approve, on an advisory basis, compensation paid to our named executive officers as disclosed in this proxy statement.
3.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2020.
4.To conduct any other business properly brought before the meeting.
|
| 2019-04-19 |
股东大会：
将于2019-05-15召开股东大会
会议内容 ▼▲
- 1.To elect the eight nominees for director named in the accompanying proxy statement to serve for the ensuing year and until their successors are elected.
2.To approve, on an advisory basis, compensation paid to our named executive officers as disclosed in this proxy statement.
3.To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of our named executive officers.
4.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2019.
5.To approve our Amended and Restated 2013 Equity Incentive Plan, to among other things, increase the aggregate number of shares of our common stock authorized for issuance under such plan by 2,500,000 shares.
6.To conduct any other business properly brought before the meeting.
|
| 2018-04-20 |
股东大会：
将于2018-05-16召开股东大会
会议内容 ▼▲
- 1.To elect the seven nominees for director named in the accompanying proxy statement to serve for the ensuing year and until their successors are elected.
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2018.
3.To conduct any other business properly brought before the meeting.
|
| 2017-04-20 |
股东大会：
将于2017-05-17召开股东大会
会议内容 ▼▲
- 1.To elect the six nominees for director named in the accompanying proxy statement to serve for the ensuing year and until their successors are elected.
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2017.
3.To approve our Amended and Restated 2013 Equity Incentive Plan, to among other things, increase the aggregate number of shares of our common stock authorized for issuance under such plan by 2,900,000 shares.
4.To conduct any other business properly brought before the meeting.
|
| 2016-04-19 |
股东大会：
将于2016-05-18召开股东大会
会议内容 ▼▲
- 1.To elect the nominees for director named in the accompanying proxy statement to serve for the ensuing year and until their successors are elected.
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2016.
3.To conduct any other business properly brought before the meeting.
|
| 2015-04-23 |
股东大会：
将于2015-05-21召开股东大会
会议内容 ▼▲
- 1. To elect the nominees for director named in the accompanying proxy statement to serve for the ensuing year and until their successors are elected.
2. To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2015.
3. To approve an increase of 1,500,000 shares in the aggregate number of shares of our common stock authorized for issuance under our 2013 Equity Incentive Plan.
4. To conduct any other business properly brought before the meeting.
|
| 2014-04-17 |
股东大会：
将于2014-05-21召开股东大会
会议内容 ▼▲
- 1. To elect the nominees for director named in the accompanying proxy statement to serve for the ensuing year and until their successors are elected.
2. To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2014.
3. To approve an increase of 900,000 shares in the aggregate number of shares of our common stock authorized for issuance under our 2013 Equity Incentive Plan.
4. To conduct any other business properly brought before the meeting.
|